Botulinum toxin treatment in spasmodic torticollis

Blackie, J D; Lees, A J
August 1990
Journal of Neurology, Neurosurgery & Psychiatry;Aug1990, Vol. 53 Issue 8, p640
Academic Journal
journal article
No abstract available.


Related Articles

  • Spasmodic torticollis.  // Mayo Clinic Health Letter;Jul1996, Vol. 14 Issue 7, p6 

    Focuses on the treatment of spasmodic torticollis. Dystonias; Botulinum toxin; Selective denervation surgery. INSET: Getting support..

  • Spasmodic torticollis. Dick, J. P. R. // Journal of the Royal Society of Medicine;Sep1992, Vol. 85 Issue 9, p517 

    The article focuses on spasmodic torticollis and discusses the characteristics of the disease and an experiment carried out for the treatment of the same. Spasmodic torticollis is produced by contraction of the cervical muscles leading to turning movements of the head. It discusses the...

  • CORRESPONDENCE.  // BMJ: British Medical Journal (International Edition);9/3/88, Vol. 297 Issue 6648, p615 

    Presents several letters in the September 1988 issue of the British Medical Journal. Use of fish oil supplementation in the treatment of rheumatoid arthritis; Effectiveness of botulinum toxin in spasmodic torticollis treatment; Association of cervical cancer with mild dyskaryosis.

  • Low dose botulinum toxin in spasmodic torticollis.  // JAMA: Journal of the American Medical Association;2/5/92, Vol. 267 Issue 5, p646 

    Highlights a study by D.F. D'Costa, et al which suggests that low doses of botulinum toxin may be equally efficacious to higher doses in the treatment of spasmodic torticollis.

  • Low dose botulinum toxin for spasmodic torticollis. Moore, A. P. // Journal of the Royal Society of Medicine;May1992, Vol. 85 Issue 5, p304 

    A letter to the editor is presented in response to an article on the use of low dose of botulinum toxin for patients with spasmodic torticollis published in the November 1991 issue.

  • botulinum toxin.  // Royal Society of Medicine: Medicines;2002, p119 

    The article presents information on botulinum toxin, a type of exotoxin produced by culturing the bacterium Clostridium botulinum. Botulinum A toxin-haemagglutin complex is mainly used for treating blepharospasm and hemifacial facial spasm, deformities due to spasticity in cerebral palsy...

  • NeuroBloc.  // Royal Society of Medicine: Medicines;2002, p389 

    This article presents information on NeuroBloc, a proprietary prescription-only preparation of botulinum B toxin. This drug is used for treating conditions characterized by abnormal muscle tone, spasmodic torticollis. It is administered through injection.

  • Lateral Torticollis: Report of a Case Complicated by Horner's Syndrome. KOÇER, Abdulkadir; Eryılmaz, Mehmet; KARATAŞ, Ayşe; ÖZDEM, Şeyma // Turkish Journal of Physical Medicine & Rehabilitation / Turkiye ;Oct2011 Supplement, p369 

    We report a 53-year-old female patient with involuntary head rotation to the right. The diagnosis of spasmodic torticollis with shoulder elevation causing the head rotation to the right side and partial Horner's syndrome (HS) were established. Complaints of the patient relieved after Botulinum...

  • Antitoxins and botulinum toxin treatment. Hambleton, Peter; Cohen, Helen E.; Palmer, Bryan J.; Melling, Jack // BMJ: British Medical Journal (International Edition);4/11/92, Vol. 304 Issue 6832, p959 

    Examines the efficacy of antitoxins and botulinum toxins as treatment for focal dystonia. Response of patients to chronic treatment; Development of toxin neutralizing antibodies; Manifestation of patients with torticollis.

  • Botulinum toxin treatment of spasmodic torticollis. Anderson, T. J.; Rivest, J.; Stell, R.; Steiger, M. J.; Cohen, H.; Thompson, P. D.; Marsden, C. D. // Journal of the Royal Society of Medicine;Sep1992, Vol. 85 Issue 9, p524 

    We reviewed the efficacy and adverse effects of repeated botulinum toxin injections into hyperactive neck muscles of 107 successive patients with spasmodic torticollis. They received 510 injection treatments over a median period of 15 months (range 3-42 months). One patient failed to benefit at...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics